ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 12.71% of NRBO shares are held by financial institutions. SUSQUEHANNA INTERNATIONAL GROUP, LLP is the top corporate investor, holding 108.54K shares valued at $51.00K. A 0.41% stake in NeuroBo Pharmaceuticals, Inc. is owned by the company. SABBY MANAGEMENT, LLC owns 93.38K shares valued at $45.00K, which translates its holding of 0.35% of the stake in the company.
Among the NRBO insiders holding of 65.23% of the stake in company, DONG-A ST CO., LTD, 10 percent owner, holds the largest shares of 2.54M. BISGAIER CHARLES PHD, Chair & Chief Scientific Off., is the second largest NRBO insider with ownership of 1.24M shares. GULLANS STEVEN R. PH.D., Interim President & CEO, stands third with possession of 930.25K shares of that stake.